|
1
|
Hochhauser E, Lahat E, Sultan M, Pappo O,
Waldman M, Sarne Y, Shainberg A, Gutman M, Safran M and Ben Ari Z:
Ultra low dose delta 9-tetrahydrocannabinol protects mouse liver
from ischemia reperfusion injury. Cell Physiol Biochem.
36:1971–1981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang X, Tan Z, Wang Y, Tang J, Jiang R,
Hou J, Zhuo H, Wang X, Ji J, Qin X and Sun B: PTPRO-associated
hepatic stellate cell activation plays a critical role in liver
fibrosis. Cell Physiol Biochem. 35:885–898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li C and Jackson RM: Reactive species
mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol
Cell Physiol. 282:C227–C241. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jaeschke H: Molecular mechanisms of
hepatic ischemia-reperfusion injury and preconditioning. Am J
Physiol Gastrointest Liver Physiol. 284:G15–G26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Montalvo-Jave EE, Piña E, Montalvo-Arenas
C, Urrutia R, Benavente-Chenhalls L, Peña-Sanchez J and Geller DA:
Role of ischemic preconditioning in liver surgery and hepatic
transplantation. J Gastrointest Surg. 13:2074–2083. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Shen J, Xiong X, Xu Y, Zhang H,
Huang C, Tian Y, Jiao C, Wang X and Li X: Remote ischemic
preconditioning protects against liver ischemia-reperfusion injury
via heme oxygenase-1-induced autophagy. PLoS One. 9:e988342014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang JW, Cho HI and Lee SM: Melatonin
inhibits mTOR-dependent autophagy during liver
ischemia/reperfusion. Cell Physiol Biochem. 33:23–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grossini E, Pollesello P, Bellofatto K,
Sigaudo L, Farruggio S, Origlia V, Mombello C, Mary DA, Valente G
and Vacca G: Protective effects elicited by levosimendan against
liver ischemia/reperfusion injury in anesthetized rats. Liver
Transpl. 20:361–375. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schulz R, Kelm M and Heusch G: Nitric
oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res.
61:402–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren G, Dewald O and Frangogiannis NG:
Inflammatory mechanisms in myocardial infarction. Curr Drug Targets
Inflamm Allergy. 2:242–256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kihara F, Inoue Y, Arima I, Ono M and
Masumoto H: Case of Recklinghausen's disease presenting as acute
porphyria in the terminal stage. Naika. 18:381–387. 1966.(In
Japanese). PubMed/NCBI
|
|
12
|
Dikmen Y, Eminoglu E, Salihoglu Z and
Demiroluk S: Pulmonary mechanics during isoflurane, sevoflurane and
desflurane anaesthesia. Anaesthesia. 58:745–748. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goff MJ, Arain SR, Ficke DJ, Uhrich TD and
Ebert TJ: Absence of bronchodilation during desflurane anesthesia:
A comparison to sevoflurane and thiopental. Anesthesiology.
93:404–408. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Puglisi F, Crovace A, Staffieri F, Capuano
P, Carravetta G, De Fazio M, Lograno G, Lacitignola L, Troilo VL,
Martines G, et al: Comparison of hemodynamic and respiratory
effects of propofol and sevoflurane during carbon dioxide
pneumoperitoneum in a swine model. Chir Ital. 59:105–111.
2007.PubMed/NCBI
|
|
15
|
Kim JW, Kim JD, Yu SB and Ryu SJ:
Comparison of hepatic and renal function between inhalation
anesthesia with sevoflurane and remifentanil and total intravenous
anesthesia with propofol and remifentanil for thyroidectomy. Korean
J Anesthesiol. 64:112–116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Erturk E, Topaloglu S, Dohman D, Kutanis
D, Beşir A, Demirci Y, Kayir S and Mentese A: The comparison of the
effects of sevoflurane inhalation anesthesia and intravenous
propofol anesthesia on oxidative stress in one lung ventilation.
Biomed Res Int. 2014:3609362014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Y, Gu C and Huang X: Sevoflurane
protects against hepatic ischemia/reperfusion injury by modulating
microRNA-200c regulation in mice. Biomed Pharmacother.
84:1126–1136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Z, Yu J, Wu J, Qi F, Wang H and Wang Z
and Wang Z: The effects of two anesthetics, propofol and
sevoflurane, on liver ischemia/reperfusion injury. Cell Physiol
Biochem. 38:1631–1642. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suzuki S, Toledo-Pereyra LH, Rodrigyez FJ
and Cejalvo D: Neutrophil infiltration as an important factor in
liver ischemia and reperfusion injury. Modulating effects of FK506
and cyclosporine. Transplantation. 55:1265–1272. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Veldhuis GJ, Willemse PH, Sleijfer DT, van
der Graaf WT, Groen HJ, Limburg PC, Mulder NH and de Vries EG:
Toxicity and efficacy of escalating dosages of recombinant human
interleukin-6 after chemotherapy in patients with breast cancer or
non-small-cell lung cancer. J Clin Oncol. 13:2585–2593. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun S, Guo M, Zhang JB, Ha A, Yokoyama KK
and Chiu RH: Cyclophilin A (CypA) interacts with NF-κB subunit,
p65/RelA, and contributes to NF-κB activation signaling. PLoS One.
9:e962112014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li G, Wu F, Yang H, Deng X and Yuan Y:
MiR-9-5p promotes cell growth and metastasis in non-small cell lung
cancer through the repression of TGFBR2. Biomed Pharmacother.
96:1170–1178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He A, Chen Z, Mei H and Liu Y: Decreased
expression of LncRNA MIR31HG in human bladder cancer. Cancer
Biomark. 17:231–236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang JJ, Liu CM, Zhang BY, Wang XW, Zhang
M, Saijilafu, Zhang SR, Hall P, Hu YW and Zhou FQ: MicroRNA-26a
supports mammalian axon regeneration in vivo by suppressing GSK3β
expression. Cell Death Dis. 6:e18652015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Teng H, Wu B, Zhao K, Yang G, Wu L and
Wang R: Oxygen-sensitive mitochondrial accumulation of
cystathionine β-synthase mediated by Lon protease. Proc Natl Acad
Sci USA. 110:12679–12684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aleckovic M and Kang Y: Regulation of
cancer metastasis by cell-free miRNAs. Biochim Biophys Acta.
1855:24–42. 2015.PubMed/NCBI
|
|
30
|
Gaur A, Jewell DA, Liang Y, Ridzon D,
Moore JH, Chen C, Ambros VR and Israel MA: Characterization of
microRNA expression levels and their biological correlates in human
cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo L, Qiu Z, Wei L, Yu X, Gao X, Jiang S,
Tian H, Jiang C and Zhu D: The microRNA-328 regulates hypoxic
pulmonary hypertension by targeting at insulin growth factor 1
receptor and L-type calcium channel-alpha1C. Hypertension.
59:1006–1013. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marques FZ, Campain AE, Tomaszewski M,
Zukowska-Szczechowska E, Yang YH, Charchar FJ and Morris BJ: Gene
expression profiling reveals renin mRNA overexpression in human
hypertensive kidneys and a role for microRNAs. Hypertension.
58:1093–1098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Safari S, Motavaf M, Seyed Siamdoust SA
and Alavian SM: Hepatotoxicity of halogenated inhalational
anesthetics. Iran Red Crescent Med J. 16:e201532014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kwan I, Bunn F, Chinnock P and Roberts I:
Timing and volume of fluid administration for patients with
bleeding. Cochrane Database Syst Rev. CD002245. 2014. View Article : Google Scholar
|
|
37
|
Lin RK, Zhang CH, Mu N, Yao QY, Dong SL,
Ai QB and Wang QX: Effects of astilbin on the expression of TNF
alpha and IL-10 in liver warm ischemia-reperfusion injury. Zhonghua
Gan Zang Bing Za Zhi. 18:463–466. 2010.(In Chinese). PubMed/NCBI
|
|
38
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther. 2(pii):
170232017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Christian F, Smith EJ and Carmody RJ: The
regulation of NF-κB subunits by phosphorylation. Cells. 5(pii):
E122016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M,
Li X and Tang H: MicroRNA-9 inhibits ovarian cancer cell growth
through regulation of NF-kappaB1. FEBS J. 276:5537–5546. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yao H, Ma R, Yang L, Hu G, Chen X, Duan M,
Kook Y, Niu F, Liao K, Fu M, et al: MiR-9 promotes microglial
activation by targeting MCPIP1. Nat Commun. 5:43862014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hao W, Zhao ZH, Meng QT, Tie ME, Lei SQ
and Xia ZY: Propofol protects against hepatic ischemia/reperfusion
injury via miR-133a-5p regulating the expression of MAPK6. Cell
Biol Int. 41:495–504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiang W, Liu G and Tang W: MicroRNA-182-5p
ameliorates liver ischemia-reperfusion injury by suppressing
Toll-like receptor 4. Transplant Proc. 48:2809–2814. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng D, He D, Lu X, Sun C, Luo Q and Wu
Z: The miR-148a alleviates hepatic ischemia/reperfusion injury in
mice via targeting CaMKIIα. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
32:1202–1206. 2016.(In Chinese). PubMed/NCBI
|
|
45
|
Zhu J, Zhu F, Song W, Zhang B, Zhang X,
Jin X and Li H: Altered miR-370 expression in hepatic
ischemia-reperfusion injury correlates with the level of nuclear
kappa B (NF-κB) related factors. Gene. 607:23–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
